EUVIMEDEUVIMED entdecken
Systematische Übersicht

Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review

Abdullah Kanbour iD, Michael Hurrell, Peter Ricciardo

ANZ Journal of Surgery · 2023-04 · 93 (4) · 869-875

DOI: 10.1111/ans.18186 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift ANZ Journal of Surgery, online erschienen am 14.12.2022. Verfasst von Abdullah Kanbour und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Royal Perth Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse type tenosynovial giant cell tumour of the temporomandibular joint (D‐TGCT‐TMJ) is a rare proliferative disorder. The aim of this study was to perform a systematic review of the literature to summarize D‐TGCT‐TMJ management regimes and recurrence rates with at least 12 months of follow‐up. Our secondary aim was to propose a minimum period of post‐operative follow‐up. A medline search for any D‐TGCT‐TMJ case detailing treatment, follow‐up of at least 12 months, and presence of recurrence was undertaken. The following variables were extracted from the studies: patient's age and sex, presence of middle cranial fossa invasion, treatment undertaken, total length of follow‐up, and presence of recurrence. All studies were assessed for bias as per the Joanna Briggs Institute systematic reviews appraisal tool. There were 63 cases reviewed and were predominantly managed with total resection (60.3%). Other modalities included: arthroplasty, subtotal resection with or without postoperative radiotherapy, medical therapy and surveillance. The recurrence rate was 9.52% and the longest follow‐up period where recurrence was observed was at 60 months. Total resection and arthroplasty are common D‐TGCT‐TMJ management regimes. Patients with D‐TGCT‐TMJ should be followed up annually for at least 5 years postoperatively to assess for recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell Tumor of Tendon SheathSynovitis, Pigmented VillonodularHumansTemporomandibular Joint

Stichwörter der Autor:innen

diffuse tenosynovial giant cell tumourfollow upmanagementpigmented villonodular synovitistemporomandibular joint

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Royal Perth Hospital, Perth, Western Australia, Australia.

ORCID-Profile: Abdullah Kanbour

Zitieren

APA

Kanbour, A., Hurrell, M., & Ricciardo, P. (2023). Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review. ANZ Journal of Surgery, 93(4), 869-875. https://doi.org/10.1111/ans.18186

Vancouver

Kanbour A, Hurrell M, Ricciardo P. Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review. ANZ Journal of Surgery. 2023;93(4):869-875. doi:10.1111/ans.18186

BibTeX
@article{Kanbour2023,
  author = {Kanbour, Abdullah and Hurrell, Michael and Ricciardo, Peter},
  title = {Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review},
  journal = {ANZ Journal of Surgery},
  year = {2023},
  volume = {93},
  number = {4},
  pages = {869--875},
  doi = {10.1111/ans.18186}
}
Kostenlos starten →